n-3 fatty acids and urinary excretion of nitric oxide metabolites in humans

American Journal of Clinical Nutrition

Volumn 65, Issue 2, 1997, Pages 459-464

  Harris, William S ^a   Rambjør, Gro Siri ^b   Windsor, Sheryl L ^b   Diederich, Dennis ^b  

^a SAINT LUKE S MID AMERICA HEART INSTITUTE   (United States)

^b NONE

Author keywords

docosahexaenoic acid; eicosapentaenoic acid; Fish oil; nitric oxide; vascular endothelium

Indexed keywords

DOCOSAHEXAENOIC ACID; FISH OIL; ICOSAPENTAENOIC ACID; NITRIC OXIDE; OMEGA 3 FATTY ACID;

ADULT; ARTICLE; ATHEROGENESIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FAT INTAKE; HUMAN; HUMAN EXPERIMENT; KIDNEY FUNCTION; NORMAL HUMAN; URINARY EXCRETION; URINE LEVEL; VASCULAR ENDOTHELIUM; VASODILATATION;

EID: 0030897717     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/65.2.459     Document Type: Article

References (73)

1. Furchgott RV, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980;288:373-6.
2. Palmer RMJ, Ferrige AC, Moncada AS. Nitric oxide accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987;327:524-6.
3. Palmer RMJ, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988;333:664-6.
4. Wennmalm A. Endothelial nitric oxide and cardiovascular disease. J Intern Med 1994;235:317-27.
5. Ludmer PL, Selwyn AP, Shook TL, Wayne RR, Mudge GH, Alexander RW. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 1986;315:1046-51.
6. Harris LM, Faggioli GL, Shah R, et al. Vascular reactivity in patients with peripheral vascular disease. Am J Cardiol 1995;76:207-12.
7. Chowienczyk PJ, Watts GF, Cockcroft JR, Ritter JM. Impaired endothelium-dependent vasodilation of forearm resistance vessels in hypercholesteroluemia. Lancet 1992;340:1430-2.
8. Tur E, Politi Y, Rubinstein A. Cutaneous blood flow abnormalities in hypertriglyceridemia. J Invest Dermatol 1994;103:597-600.
9. Gilligan DM, Guetta V, Panza JA, Garcia CE, Quyyumi AA, Cannon ROI. Selective loss of microvascular endothelial function in human hypercholesterolemia. Circulation 1994;90:35-41.
10. Baldassarre D, Gianfranceschi G, Pazzucconi F, Sirtori CR. Noninvasive assessment of unstimulated forearm arterial compliance in human subjects. Impaired vasoreactivity in hypercholesterolaemia. Eur J Clin Invest 1995;25:859-66.
11. Panza JA, Quyyumi AA, Brush JE, Epstein SE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990;323:22-7.
12. Linder L, Kiowski W, Buhler FR, Luscher T. Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo. Blunted response in essential hypertension. Circulation 1990;81:1762-7.
13. Calver A, Collier J, Vallance P. Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes. J Clin Invest 1992;90:2548-54.
14. Brennan GM, McVeigh GE, Johnston GD, Haves JR, McDermott BJ. Impaired endothelium-dependent and independent responses in noninsulin-dependent diabetes mellitus. Br J Clin Pharmacol 1991;32:648P.
15. McVeigh GE, Brennan GM, Johnston GD, McDermott BJ, McGrath LT, Henry WR. Impaired endothelium-dependent and independent responses in type 2 (non-insulin-dependcnn diabetes mellitus. Diabetologia 1992;35:771-6.
16. Gordon JB, Ganz P, Nabel EG, Fish RD, Zebede J, Mudge GH. Atherosclerosis influences the vasomotor response of epicardial coronary arteries to exercise. J Clin Invest 1989;83:1946-52.
17. Yeung AC, Vckshtein VI, Krantz DS, Vita JA, Ryan TJJ, Ganz P. The effect of atherosclerosis on the vasomotor response of coronary arteries to mental stress. N Engl J Med 1991;325:1551-6.
18. Quyyumi AA, Dakak N, Andrews NP, et al. Nitric oxide activity in the human coronary circulation. J Clin Invest 1995;95:1747-55.
19. Boger RH, Bode-Boger SM, Mugge A, et al. Supplementation of hypercholesterolaemic rabbits with L-arginine reduces the vascular release of Superoxide anions and restores NO production. Atherosclerosis 1995;117:273-84.
20. Treasure CB, Klein JL, Weintraub WS, et al. Beneficial effect of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med 1995;332:481-7.
21. Stroes ESG, Koomans HA, de Bruin TWA, Rabelink TJ. Vascular function in the forearm of hypercholesterolaemic patients off and on lipid-lowering medication. Lancet 1995;346:467-71.
22. Egashira K, Hirooka Y, Kai H, et al. Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary in patients with hypercholesterolemia. Circulation 1994;89:2519-24.
23. Lieberman EH, Gerhard MD, Uehata A, et al. Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women. Ann Intern Med 1994;121:936-41.
24. Holmes DR. An analysis of randomized trials evaluating the effect of cholesterol reduction on total mortality and coronary heart disease incidence. Circulation 1990;82:1916-24.
25. Barrett-Connor E, Bush TL. Estrogen and coronary heart disease in women. JAMA 1991;265:1861-7.
26. Stampfer M. Estrogen replacement therapy in coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med 1991;20:47-63.
27. Shimokawa H, Lam JYT, Chesebro JH, Bowie EJW, Vanhoutte PM. Effects of dietary supplementation with cod-liver oil on endotheliumdependent responses in porcine coronary arteries. Circulation 1987;76:898-905.
28. Pfister SL, Rosolowsky M, Schmilz JM, Clubb FJ, Campbell WB. Eicosapentaenoic acid alters vascular reactivity and platelet adhesion in Watanabe heritable hyperlipidemic rabbits. Eur J Pharmacol 1989;161:85-9.
29. Malis CD, Leaf A, Varadarajan GS, et al. Effects of dietary ω3 fatty acids on vascular contractility in preanoxic and posianoxic aortic rings. Circulation 1991;84:1393-401.
30. Lockette WE, Webb RC, Culp BR, Pitt B. Vascular reactivity and high dietary eicosapemaenoic acid. Prostaglandins 1982;24:631-9.
31. Joly GA, Schini VB, Hughes H, Vanhoutte PM. Potentiation of the hyporeactivity induced by in vivo endothelial injury in the rat carotid artery by chronic treatment with fish oil. Br J Pharmacol 1995;115:255-60.
32. Nagao T, Nakashima M, Smart FW, Bond RA, Morrison KJ, Vanhoutte PM. Potentiation of endothelium-dependent hyperpolarization to serotonin by dietary intake of NC 020, a defined fish oil, in the porcine coronary artery. J Cardiovusc Pharmacol 1995;26:679-81.
33. Shimokawa H, Vanhoutte PM. Dietary omega-3 fatty acids and endothelium-dependent relaxations in porcine coronary arteries. Am J Physiol 1989;256:H968-73.
34. Shimokawa H, Vanhoutic PM. Dietary cod-liver oil improves endothelium-depeiKleiit responses in hypercholesterolemic and atherosclerotic porcine coronary arteries. Circulation 1988;78:1421-30.
35. Fleischhauer FJ, Van WD, Fisehell TA. Fish oil improves endothelium-dependem coronary vasodilation in heart transplant recipients. J Am Coll Cardiol 1993;21:982-9.
36. Yamumoto H, Yoshimura H, Noma M, et al. Improvement of coronary vasomotion with eieosapeniaenoie acid does not inhibit acetylcholineinduced coronary vasospasm in patients with variant angina. Jpn Circ J 1995;59:608-16.
37. McVeigh GE, Brennan GM, Johnston GD, et al. Dietary fish oil augment nitric oxid production or release in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1993;36: 33-8.
38. Chin JPF, GUM AP, Nestel PJ, Dart AM. Marine oils dose-dependently inhibit vasoconstriction of forearm resistance vessels in humans. Hypertension 1993;21:22-8.
39. US Department of Commerce. Biomedical test materials program: drug master files for biomedical test materials produced from refined menhaden oil, and their placebos. Washington, DC: US Department of Commerce, 1989. (NOAA technical memorandum NMFS SEFC-241.)
40. Harris WS, Windsor SL, Caspermeyer JJ. Modification of lipid-related atherosclerosis risk factors by ω3 fatty acid ethyl esters in hypertriglyceridemic patients. J Nutr Biochem 1993;4:706-12.
41. Brown AJ, Pang E, Roberts DCK. Persistent changes in the fatty acid composition of erythrocyte membranes after moderate intake of n - 3 polyunsaturated fatty acids: study design implications. Am J Clin Nutr 1991;54:668-73.
42. Harris WS, Muzio F. Fish oil reduces postprandial triglyceride concentrations without accelerating lipid-emulsion removal rates. Am J Clin Nutr 1993;58:68-74.
43. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprolein cholesierol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;19:499-502.
44. Wennmalm A, Bemhin G, Edlund A, et al. Metabolism and excretion of nitric oxide in humans: an experimental and clinical study. Circ Res 1993;73:1121-7,
45. 15N]nitrate in biological fluids. Anal Biochem 1982;126:131-8.
46. Westfelt UN, Benthin G, Lundin S, Stenqvist O, Wennmalm A. Conversion of inhaled nitric oxide to nitrate in man. Br J Pharmacol 1995;114:1621-4.
47. Renier G, Skamene E, DeSanctis J, Radzioch D, Dietary n-3 polyunsaturated fatty acids prevent the development of atherosclerotic lesions in mice. Arterioscler Thromb 1993;13:1515-24.
48. Chaet MS, Garcia VF, Arya G, Ziegler MM. Dietary fish oil enhances macrophage production of nitric oxide. J Surg Res 1994;57:65-8.
49. Yaqoob P, Calder P. Effects of dietary lipid manipulation upon inflammatory mediator production by murine macrophages. Cell Immunol 1995;163:120-8.
50. Yin K, Chu ZM, Beilin LJ. Blood pressure and vascular reactivity changes in spontaneously hypertensive rats fed fish oil. Br J Pharmacol 1991;102:991-7.
51. Yin K, Chu ZM, Beilin LJ. Study of mechanisms of glucocorticoid hypertension in rats: endothelial related changes and their amelioration by dietary fish oils. Br J Pharmacol 1992;106:435-42.
52. Lee L, Webb RC, Pitt B. Eicosapentaenoic acid inhibits endothelium-dependent relaxation to acetylcholine in guinea pig coronary resistance vessels. Proc Soc Exp Biol Med 1992;200:466-71.
53. Boutard V, Fouqueray B, Philippe C, Perez J, Baud L. Fish oil supplementation and essential fatry acid deficiency reduce nitric oxide synthesis by rat macrophages. Kidney Int 1994;46:1280-6.
54. Ignarro LJ. Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein. Circ Res 1989;65:1-21.
55. Chin JPF, Kaye DM, Hurlston RM, Angus JA, Jennings GL, Dart AM. Effects of dietary marine oil supplementation on reactivity of human buttock subcutaneous arteries and forearm veins in vitro. Br J Pharmacol 1994;112:566-70.
56. Hamazaki T, Urakaze M, Sawazaki S, Yamazaki K, Taki H, Yano S. Comparison of pulse wave velocity of the aorta between inhabitants of fishing and farming villages in Japan. Atherosclerosis 1988; 73:157-60.
57. Wahlqvist ML, Lo CS, Mycrs KA. Fish intake and arterial wall characteristics in healthy people and diabetic patients. Lancet 1989;2:944-6.
58. McVeigh GE, Brennan GM, Cohn JN, Finkelstein SM, Hayes RJ, Johnston GD. Fish oil improves arterial compliance in non-insulin-dependent diabetes mellitus. Arterioscler Thromb 1994;14:1425-9.
59. Bonnema SJ, Jespersen LT, Marving J, Gregersen G. Supplementation with olive oil rather than fish oil increases small arterial compliance in diabetic patients. Diabet Nuir Metah 1995;8:81-7.
60. Bruckner G, Webb P, Greenwell L, Chow C, Richardson D. Fish oil increases peripheral capillary blood cell velocity in humans. Atherosclerosis 1987;66:237-45.
61. DiGiacomo RA, Kremer JM, Shah DM. Fish-oil dietary supplementation in patients with Raynaud's Phenomenon: a double-blind, controlled, prospective study. Am J Med 1989;86:158-64.
62. Tarry WC, Makhoul RG, L-Arginine improves endothelium-dependent vasorelaxation and reduces intimal hyperplasia after balloon angioplasty. Arterioscler Thromb 1994;14:938-43.
63. Cayatte AJ, Palacino JJ, Horten K, Cohen RA. Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemie rabbits. Arterioscler Thromb 1994;14:753-9.
64. Weiner BH, Ockene IS, Levine PH, et al. Inhibition of atherosclerosis by cod-liver oil in a hyperlipidemic swine model. N Engl J Med 1986;315:841-6.
65. Davis HR, Bridenstine RT, Vesselinoviteh D, Wissler RW. Fish oil inhibits development of atherosclerosis in rhesus monkeys. Arteriosclerosis 1987;7:441-9.
66. Kim DN, Schmee J, Baker JE, et al. Dietary fish oil reduces microthrombi over atherosclerotic lesions in hyperlipidemic swine even in the absence of plasma cholesterol reduction. Exp Mol Pathol 1993;59:122-35.
67. Parks JS, Kaduck-Sawyer J, Bullock BC, Rudel LL. Effect of dietary fish oil on coronary artery and aortic atherosclerosis in African green monkeys. Arteriosclerosis 1990;10:1102-12.
68. Burr ML, Fehily AM, Gilbert JF, et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reintarction trial (DART). Lancet 1989;2:757-61.
69. Gulp BR, Lands WEM, Lucchesi BR, Pitt B, Romson J. The effect of dietary supplementation offish oil on experimental myocardial infarction. Prostaglandins 1980;20:1021-31.
70. McLennan PL, Abeywardens MY, Charnock JS. Dietary fish oil prevents ventricular fibrillation following coronary artery occlusion and reperfusion. Am Heart J 1988;116:709-17.
71. Black KL, Culp B, Madison D, Randall OS, Lands WEM. The protective effects of dietary fish oil on focal cerebral infarction. Prostaglandins Med 1979;3:257-68.
72. Black KL, Hoff JT, Radin NS, Deshmukh GD. Eicosapentaenoic acid: effect on brain prostaglandins, cerebral blood flow and edema in ischemic gerbils. Stroke 1984;15:65-9.
73. Ellis EF, Police RJ, Yancey LM, Grabeel MN, Heizer ML, Holt SA. Effect of fish oil n - 3 fatty acids on cerebral microcirculation. Am J Physiol 1990;258:H1780-5.